TB Multimedia Resources
The high-resolution, public domain visuals below are available for use in your publication. This page will be updated as new media resources become available.
If you need more information about the data connected to the release, please click the more information button to find accompanying press releases, articles, and reports.
Although TB cases have fallen steadily since 1993, progress toward elimination has recently slowed and the COVID-19 pandemic has further strained TB prevention and control services.
Historically, U.S. health care personnel were at increased risk for latent TB infection (LTBI) and TB disease from occupational exposures, but recent data suggest that this is no longer the case. CDC and the National Tuberculosis Controllers Association have updated the 2005 CDC recommendations for testing health care personnel.
CDC released updated recommendations for use of once-weekly isoniazid-rifapentine for 12 weeks (3HP) for treatment of latent TB infection. The updated recommendations support expanded use of an effective, shorter, treatment regimen to reach even more people with latent TB infection.
Preliminary data show that while TB case counts reached a record low in 2017, the rate of decline is too slow to eliminate TB during this century.
Multidrug-resistant (MDR) tuberculosis is a major health threat globally. Nearly half a million MDR TB cases are estimated to occur worldwide annually, including cases that are extensively drug-resistant (XDR).